Title:
LAG-3 ANTIBODY HAVING HIGH AFFINITY AND HIGH BIOLOGICAL ACTIVITY, AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/238074
Kind Code:
A1
Abstract:
Provided are an LAG-3 antibody having high affinity and high biological activity, and an application thereof. In particular, provided is a new anti-LAG-3 monoclonal antibody. The antibody is capable of binding to an LAG-3 antigen with high specificity, has high affinity and biological activity, has low immunogenicity, and is used for preparing a drug for preventing or treating LAG-3 related diseases.
More Like This:
Inventors:
CAI MINGQING (CN)
PENG GUOYUAN (CN)
YU LING (CN)
FENG YUJIE (CN)
YU HAIJIA (CN)
ZHU XIANGYANG (CN)
PENG GUOYUAN (CN)
YU LING (CN)
FENG YUJIE (CN)
YU HAIJIA (CN)
ZHU XIANGYANG (CN)
Application Number:
PCT/CN2019/090979
Publication Date:
December 19, 2019
Filing Date:
June 12, 2019
Export Citation:
Assignee:
HUABO BIOPHARM SHANGHAI CO LTD (CN)
International Classes:
C07K17/00; A61K39/00; A61K39/395; C07K16/28
Domestic Patent References:
WO2017219995A1 | 2017-12-28 | |||
WO2017037203A1 | 2017-03-09 |
Foreign References:
CN102176921A | 2011-09-07 | |||
US20180127499A1 | 2018-05-10 | |||
CN108101991A | 2018-06-01 | |||
CN106103484A | 2016-11-09 |
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF: